Providing market intelligence for more than 35 years

In The News

How mHealth developers can avoid ethical dilemmas

The ethical issues around mHealth are one reason consumers are wary of health devices, and many deal closely with the privacy of what is a person's most private information. A recent Parks Associates report found that about 35 percent of consumers say they fear their health data will not remain confidential if put online, and 23 percent of broadband household owners cite privacy and security concerns in using connected health devices.

The JMIR viewpoint's authors add that there currently is no regulation of mHealth devices or apps, and no guarantee that they provide clinically accurate information. However, this summer the U.S. Food and Drug Administration released guidelines for how it intends to regulate the marketing of mHealth apps that meet the definition of medical devices.

From the article "How mHealth developers can avoid ethical dilemmas" by Judy Mottl.

Previously In The News

The Idiocy of Things Requires an “Information Habeas Corpus”!

The public is awakening to the new Orwellian threat of big data while acknowledging all its potential benefits. We do not need many of the products promoted for profit in the Internet of Things. New s...

Asthma Apps Needed, Thailand’s ‘Smart City’, More Changes At VA: TTA’s Week

Reserve soon–only a little over a week away! Hosting over 250 senior executives, the Parks Associates Connected Health Summit spotlights health technologies as part of the Internet of Things (IoT) phe...

Smart Security: IoT Advancements Create A Safer Smart Home For Consumers

Recent advances in smart security and safety devices offer consumers new and expanded solutions to help them trade in worry for peace of mind. Companies invested in IoT technologies are leading that e...

TTA’s Week: Digital Health Funding, Execs’ Wish List, ActivePreventive Responds…And Theranos

We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...